Clinical Trial Update: Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bemiparin for prophylaxis of catheter-related thrombosis in cancer patients; the study (BECAT) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Bemiparin (bemiparin)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Cancer, Thrombosis | Phase 3 | Status: TERMINATED